Penack, O., Peczynski, C., Boreland, W., Lemaitre, J., Afanasyeva, K., Kornblit, B., . . . Peric, Z. (2023). ECP versus ruxolitinib in steroid-refractory acute GVHD - a retrospective study by the EBMT transplant complications working party: Original article. Frontiers in immunology, 14, . https://doi.org/10.3389/fimmu.2023.1283034
Chicago-Zitierstil (17. Ausg.)Penack, Olaf, et al. "ECP Versus Ruxolitinib in Steroid-refractory Acute GVHD - a Retrospective Study by the EBMT Transplant Complications Working Party: Original Article." Frontiers in Immunology 14 (2023). https://doi.org/10.3389/fimmu.2023.1283034.
MLA-Zitierstil (9. Ausg.)Penack, Olaf, et al. "ECP Versus Ruxolitinib in Steroid-refractory Acute GVHD - a Retrospective Study by the EBMT Transplant Complications Working Party: Original Article." Frontiers in Immunology, vol. 14, 2023, https://doi.org/10.3389/fimmu.2023.1283034.